The objective of this review was to assess the effects of
calcium supplementation during pregnancy on hypertensive disorders of pregnancy and related maternal and child adverse outcomes.
SEARCH STRATEGY: We searched the Cochrane Pregnancy and Childbirth Group trials register and the Cochrane Controlled Trials Register and we contacted study authors.
SELECTION CRITERIA: Eligibility and trial quality were assessed. Data extraction was carried out independently by two reviewers.
MAIN RESULTS: Nine studies were included, all of good quality. There was a modest reduction in
high blood pressure with
calcium supplementation (relative risk 0.80, 95% confidence interval 0.73 to 0.88). The effect was greatest for women at high risk of
hypertension (relative risk 0.35, 95% confidence interval 0.21 to 0.57) and those with low baseline
dietary calcium (relative risk 0.49, 95% confidence interval 0.38 to 0.62). There was also a modest reduction in the risk of
pre-eclampsia with
calcium supplementation (relative risk 0. 72, 95% confidence interval 0.60 to 0.86). The effect was greatest for women at high risk of
hypertension (relative risk 0.22, 95% confidence interval 0.11 to 0.43) and those with low baseline
calcium intake (relative risk 0.32, 95% confidence interval 0.21 to 0.49). There was no overall effect on the risk of preterm delivery, although there was a reduction in risk amongst women at high risk of
hypertension (relative risk 0.42, 95% confidence interval 0.23 to 0. 78). There was no evidence of any effect of
calcium supplementation on
stillbirth or death before discharge from hospital.
REVIEWER'S CONCLUSIONS: